Via Surgical’s TissueTak Tendon Anchor Gets 510(k) Clearance

Israel-based Via Surgical has received 510(k) marketing clearance from the FDA for the TissueTak tendon anchor.

The suture-based fixation system, which is used for arthroscopic rotator cuff repair and augmentation, offers an alternative to traditional surgical staples or suture techniques.  

The TissueTak device can insert multiple fasteners that attach a patch to the patient’s tendon, without reloading or removing the device from the joint.